Silverberg Bernstein Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.62M Buy
14,267
+100
+0.7% +$23.3K 1.39% 17
2026
Q1
$3.46M Buy
14,167
+100
+0.7% +$23.3K 1.91% 15
2025
Q4
$2.91M Buy
14,067
+1,000
+8% +$198K 1.68% 19
2025
Q3
$2.42M Buy
13,067
+1,600
+14% +$274K 1.47% 20
2025
Q2
$1.75M Buy
11,467
+2,467
+27% +$379K 1.2% 24
2025
Q1
$1.49M Buy
9,000
+300
+3% +$46.9K 1.39% 23
2024
Q4
$1.26M Hold
8,700
1.11% 23
2024
Q3
$1.41M Sell
8,700
-600
-6% -$95.6K 1.29% 21
2024
Q2
$1.36M Hold
9,300
1.32% 19
2024
Q1
$1.47M Hold
9,300
1.44% 18
2023
Q4
$1.46M Buy
+9,300
New +$1.43M 1.39% 18

Other funds holding JNJ

Silverberg Bernstein Capital Management's JNJ Position: Q2 2026 in Review

Silverberg Bernstein Capital Management increased its Johnson & Johnson (JNJ) stake by 0.71% in Q2 2026, buying an estimated $23.3K and bringing the position to 14,267 shares worth $3.62M. The position accounts for 1.39% of the portfolio, ranked #17.

Silverberg Bernstein Capital Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Silverberg Bernstein Capital Management held 14,267 shares of Johnson & Johnson worth $3.62M as of Q2 2026.
  • Silverberg Bernstein Capital Management bought 100 Johnson & Johnson shares in Q2 2026, an estimated $23.3K.
  • Johnson & Johnson made up 1.39% of Silverberg Bernstein Capital Management's portfolio in Q2 2026, its #17 holding.
  • Silverberg Bernstein Capital Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Silverberg Bernstein Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.